These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 17428898
1. Intermittent intraperitoneal infusion of peptide YY(3-36) reduces daily food intake and adiposity in obese rats. Chelikani PK, Haver AC, Reidelberger RD. Am J Physiol Regul Integr Comp Physiol; 2007 Jul; 293(1):R39-46. PubMed ID: 17428898 [Abstract] [Full Text] [Related]
2. Effects of different intermittent peptide YY (3-36) dosing strategies on food intake, body weight, and adiposity in diet-induced obese rats. Reidelberger RD, Haver AC, Chelikani PK, Buescher JL. Am J Physiol Regul Integr Comp Physiol; 2008 Aug; 295(2):R449-58. PubMed ID: 18550871 [Abstract] [Full Text] [Related]
3. Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats. Chelikani PK, Haver AC, Reeve JR, Keire DA, Reidelberger RD. Am J Physiol Regul Integr Comp Physiol; 2006 Feb; 290(2):R298-305. PubMed ID: 16210414 [Abstract] [Full Text] [Related]
4. Effects of exendin-4 alone and with peptide YY(3-36) on food intake and body weight in diet-induced obese rats. Reidelberger RD, Haver AC, Apenteng BA, Anders KL, Steenson SM. Obesity (Silver Spring); 2011 Jan; 19(1):121-7. PubMed ID: 20559304 [Abstract] [Full Text] [Related]
11. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity. Roth JD, Coffey T, Jodka CM, Maier H, Athanacio JR, Mack CM, Weyer C, Parkes DG. Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760 [Abstract] [Full Text] [Related]
12. Ghrelin attenuates the inhibitory effects of glucagon-like peptide-1 and peptide YY(3-36) on food intake and gastric emptying in rats. Chelikani PK, Haver AC, Reidelberger RD. Diabetes; 2006 Nov; 55(11):3038-46. PubMed ID: 17065340 [Abstract] [Full Text] [Related]
13. PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice. Adams SH, Lei C, Jodka CM, Nikoulina SE, Hoyt JA, Gedulin B, Mack CM, Kendall ES. J Nutr; 2006 Jan; 136(1):195-201. PubMed ID: 16365082 [Abstract] [Full Text] [Related]
14. Role of capsaicin-sensitive peripheral sensory neurons in anorexic responses to intravenous infusions of cholecystokinin, peptide YY-(3-36), and glucagon-like peptide-1 in rats. Reidelberger R, Haver A, Anders K, Apenteng B. Am J Physiol Endocrinol Metab; 2014 Oct 15; 307(8):E619-29. PubMed ID: 25117406 [Abstract] [Full Text] [Related]
15. Inhibition of food intake in obese subjects by peptide YY3-36. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. N Engl J Med; 2003 Sep 04; 349(10):941-8. PubMed ID: 12954742 [Abstract] [Full Text] [Related]